Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q2 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.